between these conferences and between asco.llect money if it just sits here, which is what ibb has been doing. >> ibb is dominated by the big names. and they are not expensive. so you have that underlying component. >> but what's your take, carter? we were discussing this during the break, and you said modestly, you said i did call the top back in the end of february, precisely the top, by the way. what do you see here? >> here's the thing. once you have something that's quite extended, like the transports now, and it does indeed correct a certain percentage, do you press the short and cover some and go from there? at this particular time, the ibb is a pair of twos, not bearish or bullish. fair money, dead money. >> that's how we're trading it by the put set. >> at it again. >>> and a winning pandora trade, and a loser. it was a wild week for dan nathan, but now a plan to make for money with tech stocks. find out what it is when options action returns. [ indistinct shouting ] ♪ [ indistinct shouting ] [ male announcer ] time an

talking about next week's asco conference. is breaking that down from head quarter, meg. >> i will say this year is pharma focus. of course, it's the bier teches that always move. there's names that we're watching closely. there's a data drop a couple weeks ago. one of those names is insight. they have a hot drug in immunotherapy. analysts looking for more data that could reverse the declines we saw on the earlier data. another company we're looking at is clovi as. another one with an approved drug, ariad, who had a new drug on the market. we'll see which patients it might be used best in and there was a big mover in. pharmas. brist bristol-myers. they'll have a lot more data at the meeting they'll be looking for. whether they turn that decline down after they got that down-grade, melissa. >> meg, thanks for that. >> one of the things you see, most of those names peaked in march. >> the big space bio tech is interested in is oncology drugs. the cancer drugs. the real growth opportunities. the thing about playing any one of the

miami tiene algo de tu ascos. una temperatura mÁxima de 77.ad, baila muy bien. [♪ mÚsica ♪] ♪ a la una, a las dos, a las tres ♪ ♪ conÉctate y enlÁzate ♪ ♪ ya caÍste en la red, ya te atrapÉ ♪ ♪ por twitter, por facebook, por instagram ♪ ♪ por vine, por donde quiera que estÁs ♪ ♪ en despierta amÉrica, la bienvenida te darÁn ♪ >> eso. muy buenos dÍas. bienvenidos a casita pedro, carla, lourdes porque ya le empecÉ a escribir twitteets y la gente tiene muchas ganas de hablar con ustedes. pero una de las cosas que estÁn muy calientes son las redes sociales de alan tacher con tom cruise y las imÁgenes son histÓricas. miren este momento donde alan se tomÓ la foto con tim cuise. mÁsadelante podrán ver la entrevista en exclusiva. fuimos el Único medio hispano que se montÓ en un avión. no se imaginan lo que nos revelÓ. sigan en sintonÍa que esto se pone mucho mejor. recuerde, @despiiertaameric >> de verdad, alan fue el Único periodista o persona que fue a entrevistar a este estados unidos y latino. aviÓn privado, privado. >> yo querÍa ser azafata. >> en

certainly with the leadership of the asco. but more progress needs to be made. and to all of us who have been affected either personally or familiarly, based upon our family, regarding the issue of cancer, we stand here on the floor of the house to work together on this bipartisan -- in this bipartisan capacity and might i suggest nonpartisan capacity to make sure that as we move forward we move forward together in what i know will be a successful fight. we will win the war against cancer, we will win it working together in the best tradition of the american nation and, mr. speaker, i yield back the balance of my time. the speaker pro tempore: the gentleman yields back. under the speaker's announced policy of january 3, 2013, the gentleman from florida, mr. yoho, is recognized for 17 minutes as the designee of the majority leader. mr. yoho: thank you, mr. speaker. i rise today to recognize challenge enterprise of north florida and the ability one program. challenge enterprise employs more than 300 citizens in my district alone. are disabled persons employed on p

better known as asco. the event usually leads to a flurry of stock moves., i know you're anticipating this. what do you think here? >> well, i looked at a number of these like for instance seldex which i've talked about. and it's about a $14 stock. it's been volatile moving up and down from 11 to 16 and now about a $14 stock. breast cancer and ovarian cancer. i think this is one to watch and one that i'm holding long into next week. one i'm not holding long is phrma cyclics. traded over 90 this morning. a great sign, but many of these were down pretty good into the asco event and i think this one was certainly ripe for profit taking. so i did it. and by the end of the show, i'm sure -- or by the end of the day i'll be out of the remainder. i've already sold 50%. lastly, take a look at insight. there were a number of others and that is what i think you with a don't watch at this particular event. >> some of these moves and maybe there a tendency to move ahead of the event. >> you bet. >> blockbuster news obviously can move a sftock further. but you have to t

keep moving obviously once we get the clinical data presented at asco, both of those on your radar, too? >> they definitely are, and cancer drugs are interesting, sort of part of the equation. because a lot of these drugs, not necessarily incite's or celdex's specifically, but a lot of the cancer drugs extend life six weeks to two months, but they cost more than $100,000 a year. so this is one of the things that we're -- >> but the extension of a life is better than the alternative, correct? that's why they -- >> that's true. of course, when you're talking six weeks to two months, that could be the average of the study, not necessarily what everybody gets. some people might live a lot longer, so an important thing to think about. >> you're sort of new here. this is how steve weiss is. you'll get to understand him in a little bit. >> you'll never really understand him. she'll just get used to him. >> just discount him. >> i'll have more on the price versus value in the next hour, and you can read more about this, about the high cost of health care on cnbc.com. >> all right, thank you

. >> reporter: asco is bound to move stocks, analysts say the key thing will be drugs fighting cancer do they work? immunotherapies work in different ways, some harvest the cells, multiplying them, and reinventing into the body to fight the cancer. another drug recodes the cells to be better cancer hunters, then destroys them and finds other cancers. others are medications taken by infusion. some pack a hearty punch against cancer cells, others help immune cell cells see the enemy, revealing invisible cancer cells so the immune cells can identify the target and then attack. smaller companies like geno and kite farmer are in the sales. this weekend will give us another look at the promise of these medicines. for "nightly business report," i'm meg terrell. >>> nearly one and a half million vehicles are being recalled for safety concerns, but this time ford is the company involved. most of the effective late model cars, 900,000 of them are ford with the torque sensor inside the steering column. also the concerns are taurus sedans being recalled to update the floor mats. >>> more troublep

after hours trading from the asco cancer conference. seeing some big data drop. stocks are moving.after hours on its approved drug in pancreatic cancer. seeing good news in clovis. astrazeneca also presenting data on a similar drug people to be happy with. bristle merck. back to you, guys. >> that's one we mentioned when we discussed it with the city's analyst. >> we saw the stock within a few days. now it's back down to, guess, what, a 50 handle. they just recorded a couple weeks ago it wasn't great. it's about the cash burn and can they get things out in time. it looks like the answer might be yes. with the 12% shortage where it currently is, i think it's probably some more on the upside. >> medical marijuana is turning over a new leaf. kicking off the stigma of getting high on another ingredient. the first drug will be able to treat cannabis. it's a cannabinoid platform you're using. can you explain? >> other than thc which do not make you high and have medicinal properties. so we have been interested into a cannabinoid which appears to have effects in treating seizures in child

>> we're likely to hear a lot more about that at asco's annual meeting next week. the high cost of health care on cnbc.com. sue? >> thank you very much, meg. appreciate it. >>> to the bond market now. let's check interest rates with rick santelli at the cme. ricky? >> reporter: sue, here we hover maybe a basis point or two than we settled yesterday at 255. as you see on the intraday chart. but all things consider, kind of in holiday mode. and remember, if we look at a chart starting in november of last year, this really says it all. see that spike right on the left side of the chart? that's a 3.03 yield. we're 50 basis points lower. we're about at the exact same place we were at the end of last year with stocks. which is the reason we enjoyed michelle and steve's debate so much. the market weighs in, it didn't make anything in stocks so far this year, but you've made a bundle especially in total return. 30-year bond in total return, about 10.5%. back to you. >> thank you very much. >>> ebay saying 145 million users records have been breached make being this one of

>> well, we do have asco coming up, judge, so perhaps one of the reasons gilead is getting a lift there. and as you mentioned, the stock was down pretty hard. we're seeing the lift that goes with some of the names. as far as what i'm trading here, it remains the same for the last five days. and if you look at a chart going back even a month, take a look at the russian stocks, rsx, those two stocks up 9% to 10%. >> over 9%. >> yeah, where our market's going back and forth like this in a sawtooth. india, because of what just went on with their elections last week and modi. take a look at ibn, thing about banking stock there, rdf. these are stocks that are moving to the upside, and they're already making big moves. i think there's more in those two names to the upside. >> scott, jon, and steve, they both made a good point, which is dispersion, the differential between how stocks are acting is starting to climb here, which means there are winners and losers being separated, and we don't have to play the same game as 2013 where it was all bets on whether the whole market would advance or the

we're seeing research saturday at asco which could drive clovis up further. >> gilead, it was a ridiculous but they got caught up with the rest of the biotechs, all got sold off. the stock went from 84 in february down to 64. and it's finally getting the footing back as the rest of the space recovers. i think right now in the biotech space, gilead as interesting stock out there. >> cldx, the stock is down 40% year-to-date. and it's down, it's lost half of the value basically since it topped 30 back in february. so 14 -- i'm watching this one. they are a big cancer player. we'll see obviously the street has not been better with them. but that's one of the reasons to watch this one closely. >> switching gears a little bit, they had problems in the past with data being leaked prior to that conference. will that happen again? they try to be tight with it. that's something you have to watch. and if you see a stock starting to move you have to start to wonder. we did see a couple of stocks moving here today. especially people anticipating good data at the meeting and buying ahead of that. >> it

bristol myers over the years because of asco data has been good. >> incredible pipeline in terms of dealing with cancer. >> so now what this does is throw a little chink in things. i'm not going to be so dog mattic to say that guy doesn't know what he's talking about. this is this weekend's activity. i will go through these abstracts as best i can. >> this is him. this is all him, this guy? >> yeah. >> all right. but that's -- this stock has a lot of momentum people in it. be careful. this downgrade has gravitas. that's what i'm saying. >> time for one more. >> one that i don't think has that much gravitas. plug power. this was the peak of speculation, this was march 3rd. i was on a oil rig when this happened. >> not that you weren't getting hate tweet soos. >> people told me how could you not buy plug power. does a gigantic secondary. morgan stanley. i'm sorry $5, much more than that. what happened is it's come down and cou wan visited them and saw a lot of factory activity, they say it's time to go hold to buy plug. >> factory activity. >> why? is there a question as to whether th

. >> asco is the year's biggest event in cancer research. the biggest theme will be immuno therapy. drugs that harness the immune system to harness cancer. how do they work? >> some involve harvesting a patient's immune cells, specifically the "t" cells. multiplying them and then reintroducing them to the body to fight that cancer. another technique takes "t" cells out of the patient's body and ricohs them to be better cancer hunters and returns them to find and destroy cancer. other immunotherapies are medications patients take by intravenous infusion. others help immune cells see the enemy, revealing invisible cancer cells so immune cells can identify the target and attack. >> companies working on these therapies include bristol-myers, merck and novartis. smaller companies are also in the space. analysts say for bristol-myers alone, the drugs could bring in $13 billion in annual revenue. this weekend will give us another glimpse at the promise of these medicines. back to you guys. >>> still to come on the show, flying the next. another twitter exec hands in his notice. all the det

¿cÓmo haces para que no te de asco? >> ya.na! ah... ¿las facturas son separadas? claro! ahhhh... ¡hola, mi amor! Únete a sprint framily por tan poco como $25 al mes y, por tiempo limitado, recibe un bono por cambiarte de hasta $650. de garnier fructis. mezclas que transforman totalmente el cabello. en la ducha...marvelous nutre. al darle estilo... marvelous protege. y brilla... dónde y cuándo quieras. ibusca el tuyo! nuevo marvelous oil, de garnier fructis. imás! imás! [ riendo ] imás! [ madre ] si nos estamos divirtiendo tanto, ¿por qué parar? y el nuevo bounty tampoco para. es 2 veces más absorbente que la marca líder común, y se mantiene tan fuerte, que puedes usar menos. mira cómo una hoja del nuevo bounty sigue absorbiendo mientras las dos de ellos paran. [ riendo ] imás! por qué usar más si puedes usar menos. nuevo bounty. el que absorbe sin parar. mucha risa, y baile... [ padre ] ...y ruido. [ madre ] sí, mucho ruido. [ locutor ] honey maid teddy grahams. todos los días refrigerios saludables para todas las familias sal

siempre no le da tanto asco.demÁs participantes decÍan que la que estaba operada pero del cerebro era camila sodi y le llamaban que era muy intolerante a cierta lactosa. decÍan que no lo tomes tan a pecho, mi camila. pero les queremos comentar que quien le dio un consejazo a david zepeda fue gabriel soto. no fue sobre los mÚsculos, sobre cÓmo arreglarse el cabello, ni los rayos. no. fue sobre su carrera como cantante. escuchen lo que dijo. esto es lo que dice. >> recibÍ muchas críticas, lo cual fue complicado para mÍ. es un proyecto que me costÓ, que produje y por un error de producciÓn o de un momento tomar una decisiÓn que no estaba planteada asÍ de cantar en vivo en un programa en vivo que estÁ complicadÍsimo. lo felicito y lo aplaudo. >> ¿quÉ le recomiendas? >> que no cante en vivo si no estÁ preparado porque eso fue lo que me pasÓ a mÍ. nadie canta en vivo en tele. >> y es que el regreso de gabriel soto como cantante fue regreso y despedida porque tanto en vivo en un programa nacional y cantÓ bastante mal. ¿

. >> asco. >> may 30th to june 3, chicago. >> are you going? >> i am.re hoping to do a few interviews with you. >> she went to wellsly. >> that is why. >> really? i have to rethink my whole southern sisters. >> the english major i had there was very helpful. >> excellent. thank you. coming up, senator bob corker. cory booker. on the -- here i thought we had core where booker. it's bob corker. >> it is like when i said twitter was going to open flat. it is exactly like that. i can see the confusion. on the need for mortgage insurance reform, sanctions against russia. and volkswagen in chattanooga. check out the futures at this hour. oh! the name your price tool! you tell them how much you want to pay, and they help you find a policy that fits your budget. i told you to wear something comfortable! this is a polyester blend! whoa! uh...little help? i got you! unh! it's so beautiful! man: should we call security? no, this is just getting good. the name your price tool, still only from progressive. i'm spending too much time hiring and not enough time in my

this has been a fis asco. billions of dollars. some think they're going to get out of canada.hey're going to do that. it does have a yield. the dividend seems sach fe to m. always seems to be someone who wants to buy every retailer who gets hit thinking this is the last bad quarter. this is probably not the last for target. i think you have to give it room. >> if they could this today, reporting tomorrow and we know the ceo is booked tomorrow to talk about the numbers. i mean, and a lot of times they'll -- whatever the last ceo did they put it in this quarter to get it out of the way too. i'm wondering how bad it could be or not going to be bad? >> i think look, if you get this at 3.5% yield, still a growth company, not a bad company, it has a lot of adhere rence. but i look at so many other retailers doing well. none of them today, though. i mean everybody that's reported today is sub par. >> yeah. yeah. all right. >> going to keep it short. we will see you in six minutes or so. >> thank you. >> when we come back retailers ready to report. we've heard from dick's, tjx and sta

. >> nosotros respetamos el hecho de que como toda mujer embarazada le gane el asco, antojitos. les querÍamos decir que tenemos un dÍa especial dedicado a todas las mamis. puede ser que algunas vengan. >> yo quiero aprovechar y saludar a la mÍa en puerto rico. te amo, eres la mejor y a las nanas de mi bebÉ. >> eres una extraordinaria presentadora. felicidades. a ver si vienes la prÓxima semanita. >> que regrese, que regrese! >> gracias. >> y recuerden que maÑana los esperamos temprano con muchas sorpresas para festejar a las mamis. como les dije hay cositas preparadas. >> ya estamos celebrando desde hoy con el invitado. >> y calentando motores para el lunes. >> ¿quiÉn se nos va? >> este es mi regalo para todas las mamÁs de despierta amÉrica. >> y de cumpleaÑos adelantado. >> raphael! [♪ mÚsica ♪] ♪ no te olvides que Él y yo somos amigos ♪ ♪ y me duele hacer contigo lo que pides sin hablar ♪ ♪ no te olvides que soy hombre y no de hierro ♪ ♪ y hoy darÍa el mundo entero por no verte nunca mÁs ♪ ♪ tÚ no sigas procurando verme a solas ♪ ♪ y acercÁndome tu boca ♪ ♪ cuando te voy a bes

got eight percent of the vote and you've got all these dark biggers behind the scenes you've got the asco you've got chinese box still controlling much of government you've got your old who city the results were announced just said i'm off back to the east to continue fighting so we push him because the figurehead when you've got all these don't begin of course to michel because well behind controlling manipulating what is a very dark picture going on in ukraine at the moment you know john one of the things i find so disappointing from western media and western governments you know first of all because they don't don't have the humanity to care about civilians being killed but what bothers me even more is that they whitewashed this truly disgusting regime in keir and you know in the center of europe after you know i was celebrated mainly here in moscow and i'm sure i can see from your lapel that you did to i mean how how in the world can the west continue to whitewash this because we because sooner or later like i said this can this revolution is going to consume itself and then they're g

you are going to have asco coming up and thought perhaps astrazeneca will have positive things that areeleased there that will embolden their investment. listen, there can be more of a conversation under uk takeover law between the shareholders and the company that wants to acquire their shares. >> okay. >> and most conversations are taking place between pfizer and that shareholder base. they're giving them a sense as to where to go. astrazeneca ceo is still stuck in australia because he doesn't want to get on a plane to come back because he wants to stay in touch at all times. >> $100 billion. this is a huge -- >> and this letter to the prime minister of the uk, david cameron. >> important. >> by ian reed. >> important they line up potential support there. that certainly defeats what might be an otherwise potent opposition. >> all right. put me in the room -- put me in the room. >> of the deal in terms of uk. >> i never thought of pfizer as being this rough and tumble group of people. this is bare knuckles, isn't it? what is it like in there? >> they're just trying to figure out what's

reach a deal to come home again joining our from our los angeles studio for more on this is richard ascosenior fellow at campaign for america's future and host of the zero hour richard welcome back thanks tom always good to be here ok richard what do you make of the thank you it's always great to have you here what do you make of the snowden interview with the big takeaway here. well i think for the first big takeaway and by the way i'm just speaking for myself here and for the zero hour but i think the first big takeaway is that the interview happened you know i we've had a year of demonization of this guy trying to frame him as a loner as selfish as irrational as a kid and he's been been inaccessible to the american media so i think the fact that he reached out the fact that n.b.c. allowed him to speak for an hour in a way it felt like the breaking of an embargo whether there was an intentional one or not and i think it's important it's an important moment for the american people to see the person who's been so demonized speak for himself how big of a deal is that that's gave this inte